0001209191-20-054996.txt : 20201015 0001209191-20-054996.hdr.sgml : 20201015 20201015202630 ACCESSION NUMBER: 0001209191-20-054996 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201015 FILED AS OF DATE: 20201015 DATE AS OF CHANGE: 20201015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horowitz Limited Partnership VIII CENTRAL INDEX KEY: 0001827839 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 201242555 BUSINESS ADDRESS: STREET 1: 5030 CAMPUS DRIVE, SUITE A CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: (949) 831-5158 MAIL ADDRESS: STREET 1: 5030 CAMPUS DRIVE, SUITE A CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-15 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001827839 Horowitz Limited Partnership VIII 5030 CAMPUS DRIVE, SUITE A NEWPORT BEACH CA 92660 0 0 1 0 Series A Preferred Stock Common Stock 1434790 D Series B Preferred Stock Common Stock 245966 D Series C Preferred Stock Common Stock 71427 D Series A Preferred Stock Common Stock 43151 I By the Adam S. Horowitz Revocable Trust Series B Preferred Stock Common Stock 7396 I By the Adam S. Horowitz Revocable Trust The Series A Preferred Stock shall automatically convert into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock has no expiration date. The Series B Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date. The Series C Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series C Preferred Stock has no expiration date. The shares are held by the Adam S. Horowitz Revocable Trust, of which Adam S. Horowitz is Trustee. Adam S. Horowitz is affiliated with Horowitz Limited Partnership VIII. /s/ Jason Tester, as Chief Financial Officer of Horowitz Management, Inc., the managing partner of Horowitz Limited Partnership VIII 2020-10-15